Wikidata

(Q62062861)

English

VRD as Induction Followed by IR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma

clinical trial

In more languages

Statements

title
Lenalidomide, Bortezomib, and Dexamethasone Combination Therapy as Induction Followed by Ixazomib and Lenalidomide Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma (English)
0 references
start time
10 January 2019
0 references
end time
30 September 2020
0 references
number of participants
50
0 references
research intervention
dexamethasone acetate
0 references
(RS)-cyclophosphamide
0 references
(RS)-lenalidomide
0 references
ixazomib
0 references
thalidomide
0 references
bortezomib
0 references
glycine
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62062861&oldid=2136183313"